Lonza Group AG

Lonza Group AG is a prominent multinational chemical and biotechnology company. It primarily focuses on the development and manufacture of products and services for the pharmaceutical, biotechnology, and specialty chemical markets. With its comprehensive range of services, Lonza plays a crucial role in facilitating the production of biopharmaceuticals, including monoclonal antibodies, cell therapies, and vaccines. The company impacts various sectors, notably healthcare and life sciences, by offering contract development and manufacturing solutions that support companies in bringing new therapeutics and chemical products to market efficiently. Headquartered in Basel, Switzerland, and founded in 1897, Lonza holds a significant position within the global market due to its expertise and innovation in life sciences. It collaborates with emerging biotech firms to large-scale pharmaceutical companies, underscoring its role as a key enabler in the production of cutting-edge medical technologies and treatments.